Our Mission
Myeloma BioBank is dedicated to providing researchers with the highest quality blood and bone marrow samples for multiple myeloma and other plasma cell dyscrasias, including MGUS, amyloidosis, and Waldenstrom’s macroglobulinemia.
Our mission is to accelerate the discovery of new treatments and cures for these diseases through the provision of exceptional samples.
Our Story
James R. Berenson, MD
Founder
The Institute for Myeloma & Bone Cancer Research (IMBCR) was founded by James R. Berenson, MD in 2003
-
The Berenson Cancer Center is dedicated to the treatment of patients with Multiple Myeloma
-
Dr. Berenson has published nearly 300 peer-reviewed articles in top scientific and clinical journals
-
He has recently reported the longest survival rate in the world for patients with Multiple Myeloma*
*Targeted Oncology 2023
Meet the Team
Our team of experienced professionals are dedicated to providing researchers with the highest quality samples.
We understand the critical role that biospecimens play in the study of multiple myeloma and other plasma cell dyscrasias, and we are committed to providing exceptional samples to accelerate the discovery of new treatments and cures for these diseases.
Zakir Khan, PhD
Lab Director
Marissa-Skye Goldwater
Sean Bujarski
Mingjie Li
Stacy Behare
Address
9201 Sunset Blvd, Ste 300
West Hollywood, CA 90069